ALX Oncology Holdings Inc (ALXO)
1.29
+0.08
(+6.61%)
USD |
NASDAQ |
Nov 21, 16:00
1.29
0.00 (0.00%)
Pre-Market: 20:00
ALX Oncology Holdings Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2020 | 9.11% |
March 31, 2020 | 9.01% |
December 31, 2019 | 9.07% |
Date | Value |
---|---|
September 30, 2019 | 9.08% |
June 30, 2019 | 9.11% |
March 31, 2019 | 9.11% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
9.01%
Minimum
Mar 2020
9.11%
Maximum
Jun 2020
9.06%
Average
9.07%
Median
Dec 2019
Gross Profit Margin (Quarterly) Benchmarks
Biomarin Pharmaceutical Inc | 74.73% |
Neurocrine Biosciences Inc | 98.71% |
Eton Pharmaceuticals Inc | 61.04% |
Verve Therapeutics Inc | -- |
Immuneering Corp | -- |